Latest nephrology News

Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care
Advances in Understanding the Evolution of Stomach Loss in Agastric Fishes
How to keep your kidneys healthy – and how to spot when things are going wrong
Researchers establish India’s first national benchmark for survival among haemodialysis patients
The Evolutionary Timeline of Diminished Boric Acid and Urea Transportation in Aquaporin 10
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
CSL announces seven new Global Research Acceleration Initiative projects
Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer
CSL reports strong profit growth with record plasma collections
First-in-class treatment delivers major advance for incurable kidney disease
Women need to be better represented on Australian clinical practice guideline panels
Positive CHMP Opinion Etranacogene Dezaparvovec
Ashurst advises lenders on expansion financing for Sanecum
CSL Announces Next CEO & Managing Director
CSL Closing of Arcturus Therapeutics Agreement
Improving environmental sustainability of dialysis services
AstraZeneca advances scientific leadership in cardiovascular and renal diseases with over 60 abstracts collectively
Consensus-based recommendations for acute kidney injury in children
Prevalence of chronic kidney disease “alarmingly” high
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
New low-cost dialysis system can make medical grade water in home, giving green light to progress to clinical trials
Regular paracetamol use linked to raised blood pressure
Collaborative research approach set to accelerate treatment of rare kidney condition
CSL Publishes Vifor Offer Prospectus
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006